Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MAGALI VAN DEN BERGH

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1568717544
CMS profile
2782269
Location
FORT MYERS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$4,071.03

174 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $4,069.74 173
Education $1.29 1

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
PFIZER INC. $316.53 11
Incyte Corporation $242.34 12
AstraZeneca Pharmaceuticals LP $218.38 5
Janssen Biotech, Inc. $200.29 11
Astellas Pharma US Inc $193.55 12
Daiichi Sankyo Inc. $187.82 9
Celgene Corporation $179.74 8
Merck Sharp & Dohme LLC $178.96 9
GlaxoSmithKline, LLC. $160.74 8
Novartis Pharmaceuticals Corporation $139.84 6
Amgen Inc. $137.49 2
INTUITIVE SURGICAL, INC. $133.82 1
Exelixis Inc. $108.16 5
BeOne Medicines USA, Inc. $99.49 4
Sumitomo Pharma America, Inc. $93.37 5
E.R. Squibb & Sons, L.L.C. $86.95 4
Gilead Sciences, Inc. $77.56 3
ARRAY BIOPHARMA INC $76.14 3
Takeda Pharmaceuticals U.S.A., Inc. $73.06 3
Legend Biotech USA Inc. $72.79 2
Janssen Scientific Affairs, LLC $70.76 2
GENZYME CORPORATION $70.12 4
Regeneron Healthcare Solutions, Inc. $61.79 3
SpringWorks Therapeutics, Inc. $57.80 2
ABBVIE INC. $51.28 2
Lilly USA, LLC $50.59 2
TerSera Therapeutics LLC $50.35 2
Menarini Silicon Biosystems, Inc. $50.12 3
Alexion Pharmaceuticals, Inc. $46.10 2
Eisai Inc. $43.87 2
Iovance Biotherapeutics, Inc. $43.51 2
JAZZ PHARMACEUTICALS INC. $42.59 2
Dendreon Pharmaceuticals LLC $40.97 2
PUMA BIOTECHNOLOGY, INC. $32.50 2
Kite Pharma, Inc. $31.33 2
PharmaEssentia USA Corporation $31.01 1
Stemline Therapeutics Inc. $27.42 1
KYOWA KIRIN, INC. $24.51 1
Genmab U.S., Inc. $24.17 1
SUN PHARMACEUTICAL INDUSTRIES INC. $23.52 1
SOBI, INC $21.89 1
Bayer Healthcare Pharmaceuticals Inc. $21.77 1
TOLMAR, INC. $21.56 1
Amneal Pharmaceuticals LLC $20.92 1
Spectrum Pharmaceuticals Inc. $20.28 1
TAIHO ONCOLOGY, INC. $18.21 1
Tempus AI, Inc $17.61 1
Immunocore Limited $16.96 1
Genentech USA, Inc. $16.64 1
SERVIER PHARMACEUTICALS LLC $16.09 1
Fennec Pharmaceuticals, Inc. $16.02 1
pharmaand GmbH $11.75 1

Page 3 of 4; records 101–150 of 174 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MAGALI VAN DEN BERGH

NPI 1568717544 · CMS profile ID 2782269

Allopathic & Osteopathic Physicians / Internal Medicine / Medical Oncology

FORT MYERS, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 174 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1568717544?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MAGALI VAN DEN BERGH, NPI 1568717544, CMS profile ID 2782269. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 174 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1568717544?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MAGALI VAN DEN BERGH, NPI 1568717544, CMS profile ID 2782269. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 174 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1568717544?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MAGALI VAN DEN BERGH, NPI 1568717544, CMS profile ID 2782269, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 174 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1568717544?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

174 matching records · $4,071.03 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 174 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 174.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Daiichi Sankyo Inc. $27.1605/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197098813 CMS
Amgen Inc. $121.8505/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228367229 CMS
Tempus AI, Inc $17.6105/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250352806 CMS
Regeneron Healthcare Solutions, Inc. $15.9704/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213062942 CMS
Janssen Biotech, Inc. $23.2304/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175083768 CMS
Daiichi Sankyo Inc. $17.9504/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197061227 CMS
Menarini Silicon Biosystems, Inc. $14.3404/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199866075 CMS
Spectrum Pharmaceuticals Inc. $20.2804/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1221049945 CMS
Sumitomo Pharma America, Inc. $16.1704/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1176731596 CMS
Celgene Corporation $26.2904/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184589443 CMS
Janssen Biotech, Inc. $23.5104/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175083562 CMS
Merck Sharp & Dohme LLC $24.1904/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238144558 CMS
Novartis Pharmaceuticals Corporation $28.4504/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200415965 CMS
Janssen Biotech, Inc. $28.5404/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175085680 CMS
Fennec Pharmaceuticals, Inc. $16.0204/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250855985 CMS
PUMA BIOTECHNOLOGY, INC. $14.3504/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251745954 CMS
AstraZeneca Pharmaceuticals LP $24.0404/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206705072 CMS
BeOne Medicines USA, Inc. $31.0404/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202902020 CMS
Janssen Scientific Affairs, LLC $29.0904/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174158275 CMS
Daiichi Sankyo Inc. $28.7303/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197052329 CMS
AstraZeneca Pharmaceuticals LP $20.5203/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206323407 CMS
ARRAY BIOPHARMA INC $31.0503/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228968816 CMS
PFIZER INC. $12.3003/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229562842 CMS
TOLMAR, INC. $21.5603/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237019298 CMS
AstraZeneca Pharmaceuticals LP $27.7403/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207013190 CMS
PFIZER INC. $9.4303/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229443350 CMS
Janssen Biotech, Inc. $17.0503/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175084943 CMS
Genentech USA, Inc. $16.6403/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211539210 CMS
Astellas Pharma US Inc $16.7303/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238761056 CMS
Dendreon Pharmaceuticals LLC $17.0103/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1245011391 CMS
Astellas Pharma US Inc $20.5403/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238758750 CMS
ABBVIE INC. $26.0503/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204614531 CMS
Stemline Therapeutics Inc. $27.4203/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244098212 CMS
PharmaEssentia USA Corporation $31.0103/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246830076 CMS
Celgene Corporation $32.6502/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184589431 CMS
TAIHO ONCOLOGY, INC. $18.2102/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211412718 CMS
Merck Sharp & Dohme LLC $26.4102/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238098838 CMS
SOBI, INC $21.8902/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240260348 CMS
E.R. Squibb & Sons, L.L.C. $22.4202/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184589423 CMS
Celgene Corporation $26.2402/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184589417 CMS
Celgene Corporation $8.7902/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184589415 CMS
JAZZ PHARMACEUTICALS INC. $19.0202/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234338397 CMS
PUMA BIOTECHNOLOGY, INC. $18.1502/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251744168 CMS
Genmab U.S., Inc. $24.1702/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235922125 CMS
ARRAY BIOPHARMA INC $31.1002/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228987894 CMS
Novartis Pharmaceuticals Corporation $35.0402/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200415961 CMS
Astellas Pharma US Inc $14.1102/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238736700 CMS
Eisai Inc. $24.5402/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244495002 CMS
SERVIER PHARMACEUTICALS LLC $16.0902/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229104505 CMS
AstraZeneca Pharmaceuticals LP $26.1601/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207027673 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,517.33 97
PY2020 $2,703.13 88
PY2021 $9,218.85 139
PY2022 $3,116.80 163
PY2023 $4,745.90 131
PY2024 $3,276.88 167
PY2025 $4,071.03 174

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $21,715.65 9
PY2023 Principal investigator $283,162.80 19
PY2022 Principal investigator $35,718.29 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

9 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Aadi Bioscience, Inc. $2,500.00 07/02/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479085
Principal investigator 1 Aadi Bioscience, Inc. $2,500.00 07/02/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479087
Principal investigator 1 Aadi Bioscience, Inc. $2,500.00 05/24/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479073
Principal investigator 1 Aadi Bioscience, Inc. $2,500.00 04/19/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479065
Principal investigator 1 Aadi Bioscience, Inc. $2,500.00 04/01/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479051
Principal investigator 1 Aadi Bioscience, Inc. $2,500.00 03/08/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479041
Principal investigator 1 Aadi Bioscience, Inc. $500.00 03/08/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479043
Principal investigator 1 Aadi Bioscience, Inc. $3,715.65 01/17/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479025
Principal investigator 1 Aadi Bioscience, Inc. $2,500.00 01/17/2024 Non-covered Recipient Entity
Sarah Cannon Research Institute LLC
A Phase 2 Multi-center Open-label Basket Trial of Nab-sirolimus for Adult and Adolescent Patients With Malignant Solid Tumors Harboring Pathogenic Inactivating Alterations in TSC1 or TSC2 Genes No dispute reported 06/30/2026 1082479027